Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. 

CEO
Daniel R. Passeri
CEODaniel R. Passeri
Employees
53
Employees53
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
53
Employees53

CUE Key Statistics

Market cap
67.43M
Market cap67.43M
Price-Earnings ratio
-1.14
Price-Earnings ratio-1.14
Dividend yield
—
Dividend yield—
Average volume
1.40M
Average volume1.40M
High today
$1.15
High today$1.15
Low today
$1.04
Low today$1.04
Open price
$1.07
Open price$1.07
Volume
312.21K
Volume312.21K
52 Week high
$3.25
52 Week high$3.25
52 Week low
$0.45
52 Week low$0.45
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.